Delivery Order SPE2DB22D2206-SPE2DB25FKB49
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,262.85 to AmerisourceBergen Drug Corp for the supply of IMFINZI (500 mg/10 mL vial, 10 mL). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded, non-set-aside procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. IMFINZI is an oncology medication used in cancer...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $18,567.99 and a firm fixed price structure. This non-competitive delivery order is set to be completed by June 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation, indicating that it was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of IMFINZI (an oncology medication) in 120 mg/2.4 mL vials with a ceiling value of $6,344.80. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $23,873.13 for IMFINZI 500 mg/10 mL vials under a firm fixed-price contract with the Defense Department's Medical Supply Chain. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. IMFINZI is a prescription oncology medication, and this order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMFINZI 500 MG/10 ML vials valued at $26,525.70 with a firm fixed price structure. This contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $53,051.40 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 24, 2025, with performance occurring at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $6,344.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of IMFINZI (120 mg/2.4 mL vials). This is a non-set-aside contract with an ultimate completion date of September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the vendor's corporate office location in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB49Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. IMFINZI is a specialized oncology pharmaceutical product, reflecting the breadth of medical supplies that AmerisourceBergen delivers to support federal healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting mechanisms designed to meet varied and ongoing medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 9/23/25 |